JENKEM(SH:688356) Xin Lang Zheng Quan·2025-11-13 05:52Core Viewpoint - JianKai Technology's stock price has experienced fluctuations, with a year-to-date increase of 54.36% but a recent decline in the last five trading days by 5.13% [2] Group 1: Stock Performance - As of November 13, JianKai Technology's stock price was 87.66 CNY per share, with a market capitalization of 5.317 billion CNY [1] - The stock has seen a net outflow of 4.8918 million CNY in principal funds, with large orders buying 2.3557 million CNY (4.87%) and selling 7.2475 million CNY (14.99%) [1] - Year-to-date, the stock has been on the龙虎榜 once, with a net purchase of 39.1731 million CNY on July 21 [2] Group 2: Financial Performance - For the period from January to September 2025, JianKai Technology reported revenue of 211 million CNY, a year-on-year increase of 13.47%, and a net profit attributable to shareholders of 40.7246 million CNY, up 24.72% [2] - The company has distributed a total of 178 million CNY in dividends since its A-share listing, with 99.8755 million CNY distributed in the last three years [3] Group 3: Company Overview - JianKai Technology, established on October 9, 2001, and listed on August 26, 2020, is located in Beijing and specializes in the research, production, and sales of medical-grade polyethylene glycol and its active derivatives [2] - The company's main revenue sources are product sales (96.79%), technology usage fees (2.91%), and transportation services (0.30%) [2] - The company operates within the pharmaceutical and biotechnology sector, focusing on chemical pharmaceuticals and raw materials, with concepts including anti-cancer drugs and medical devices [2]